Vitaprost® has an organotropic effect on the prostate gland. Reduces the degree of edema, leukocyte infiltration of the prostate, normalizes the secretory function of epithelial cells, increases the number of lecithin grains in the secretion of the acini, stimulates the muscle tone of the bladder. Improves microcirculation in the prostate gland due to a decrease in thrombus formation, antiplatelet activity, prevents the development of venous thrombosis in the prostate gland.
Based on the data of clinical studies, it is proved that Vitaprost® moderately reduces the volume of the prostate gland. The drug reduces the severity of obstructive and irritative symptoms in benign prostatic hyperplasia, which is expressed in an increase in the maximum and average volumetric flow rates of urine flow and a decrease in the volume of residual urine.
Clinical studies have shown that the use of Vitaprost ® reduces the likelihood of exacerbations of chronic abacterial prostatitis, does not cause changes in the parameters of clinical and biochemical blood analysis, general urine analysis. The effectiveness of Vitaprost® for the prevention of exacerbations of chronic abacterial prostatitis is estimated at 97.5% by the researchers.
Vitaprost® normalizes the parameters of the secretion of the prostate gland and ejaculate. Reduces pain and discomfort caused by prostatitis, eliminates dysuric phenomena, improves copulatory function.